Carl Zeiss Meditec Inc.
!%Carl Zeiss Meditec Inc.%! of Dublin, Calif., has announced
that the Mel 80 excimer laser has received premarket approval for the treatment
of hyperopia, or farsightedness, from the FDA. This hyperopia indication complements
existing FDA-approved applications of the surgical laser for myopia and astigmatism,
according to the company. It will allow the company to offer a broader range of
treatment options to refractive surgeons and their patients. The device combines
high-grade optics and advanced laser technology. Clinical results of the Mel 80
study for hyperopia were presented in March at the American Society of Cataract
and Refractive Surgery in San Diego.
LATEST NEWS